Red blood cell antigen alloimmunization: Mysteries still unsolved
نویسنده
چکیده
Article history: Received 10 June 2016 Accepted 10 June 2016 Available online 16 June 2016 pletion studies. They confirm the profound effect of storage on alloimmunization in this clear-cut model but also observe that NLRP3/ caspase-1 is not required for the effect (Gibb et al., 2016). While these data reject a relevant hypothesis that NLRP/caspase-1 is required (e.g. negative data), they do not reject a potential involvement of NLRP/caspase-1, due to the potential for redundant pathways that
منابع مشابه
Red Blood Cell Alloimmunization in Patients with Thalassemia Major and Intermediate in Southwest Iran
Background: Transfusion is the mainstay treatment of patients with thalassemia major and occasionally in thalassemia intermediate. Alloimmunization is an unwanted side effect of blood transfusion. The present study intended to determine the frequency of alloimmunization in patients with β- thalassemia major and thalassemia intermediate in Southwest Iran. Patients and Methods: This was a cross-...
متن کاملRed Blood Cells Alloimmunization and Autoimmunization in Multi-transfused Thalassemia Patients in South of Iran
Background: Recurrent blood transfusion is a common treatment in patients with thalassemia. The development of antibodies against red blood cell (RBC) antigens complicates RBC cross-matching, enhances the in vivo destruction of transfused cells, accelerates tissue iron overloading, delays the provision of safe transfusion, and reduces health-related quality of life. Materials and Methods: In t...
متن کاملPrevalence of Alloantibodies and Autoantibodies in Transfusion Dependent Thalassemia Patients
Background: The development of anti-red blood cell alloantibodies remains a major problem in transfusion of blood in thalassemia major patients. Also, Autoantibodies can result in clinical hemolysis and difficulty in cross-matching blood. We studied the frequency of red blood cell alloimmunization and autoimmunization among thalassemia patients who received regular transfusions in Ilam province...
متن کاملRed blood cell alloimmunization in sickle cell disease: listen to your ancestors.
Red blood cell (RBC) alloimmunization occurs in approximately 30% of transfused sickle cell disease patients compared to 2-5% of all transfusion recipients. Because RBC transfusion is an important part of therapy in sickle cell disease, the need for additional antigen matching once alloimmunization occurs is problematic and leads to therapeutic limitations. Thus, identification of risk factors ...
متن کاملTIGIT-positive circulating follicular helper T cells and sickle cell alloimmunization.
Transfusion therapy remains an important treatment modality for patients with sickle cell disease (SCD). Despite its therapeutic benefits, red blood cell transfusion results in the development of antibodies against disparate antigens on transfused red cells (alloimmunization) in approximately 20-50% of patients with SCD. Alloantibodies can cause delayed hemolytic transfusion reactions, which in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 9 شماره
صفحات -
تاریخ انتشار 2016